Scientific Advisory Board (SAB)

The Scientific Advisory Board will provide final study approval to any required trial amendments representing the key aspects of activities of the project, as indicated by the Work packages. The Scientific Advisory Board will ensure a high standard of research and monitor the progress of the project by taking part in the annual General Assembly meetings. Whenever appropriate, it will consult the consortium and make recommendations as to improve their performance.

Prof. Dr. Cillian Twomey

Cillian Twomey

Prof. Cillian Twomey graduated in medicine in UCC in 1970 and spent his first 5 years working in Cork in the acute hospital sector and general practice. In 1975 he went to the UK to pursue specialist training in geriatric medicine and general internal medicine initially in London and later in Liverpool.  He returned to Cork in April 1979 as the second consultant physician in geriatric medicine at Cork University and St. Finbarr’s Hospitals, with teaching responsibilities to the medical school in UCC.  He retired from clinical practice in November 2010 but remains active in a range of spheres including being a member to the Board of the Health Information & Quality Authority and the Intern Network Coordinator for the South Intern Network, linked with UCC, as part of the National Intern Training programme. He is also member, and current Chairman, to the Board of Directors of St. Patrick’s Hospital (Cork) Ltd. Incorporating Marymount University Hospice and Chairman of the National Steering Committee of the Hospice friendly. In the PROSPER Study he is co-investigator, representing University College Cork. This study explored the benefits of Statin (in this case pravastatin) in the reducing cardiac events, stroke and cognitive impairment in older patients with a history of vascular disease or at risk of such events. PROSPER was one of the first multi-centre studies that exclusively included older patients only (ages ranged from 70-82 years). In October 2006 he was invited to deliver the Annual Trevor Howell Guest Lecture at the autumn scientific meeting of the British Geriatrics Society in Harrogate. The title of his lecture was: ‘Geriatric Medicine in Ireland – a 40-year journey‘. He served as President of the Irish Gerontological SocietyEuropean Union of Medical Specialists Council of UEMS Advisory Committee on Medical Training. Contact

Prof. Dr. Tischa van der Cammen

Tischa van der Cammen

Tischa van der Cammen (MD, PhD, FRCP) has been Associate Professor in Geriatrics at the Erasmus University Medical Center in Rotterdam, where she now holds a honorary appointment as Senior Lecturer in Geriatrics. She received her training in Geriatric Medicine at University College Hospital London, where she co-founded the 1st Memory Clinic in the U.K. in 1982. She was the 1st geriatrician appointed at the Erasmus University Medical Center in Rotterdam (1987), where she founded the Department of Geriatrics, the Memory Clinic and the Falls Prevention Clinic. She was Head of the Department of Geriatrics between 1987-2011. In 1991 she obtained a PhD in Medicine at the Erasmus University for her thesis ‘Diagnostic Approaches and Management Aspects of Early Dementia’. She is a member of many national and international scientific societies on ageing. In June 2008 she was awarded Fellowship of the Royal College of Physicians London for her services to geriatrics on an international level. Since July 2008 she is a member of the Professorial Board of the European Academy for Medicine of Ageing. She is a reviewer for both national and international journals on aging, and has extensive knowledge of and expertise in the field of pharmacotherapy and adverse drug reactions in old age. Her publications cover aspects of dementia, comprehensive geriatric assessment, falls, drug-related falls, and drug effects in old age. Her presence in the SENATOR project is associated to her large experience in the field of adverse drug reactions in older persons.Contact

Prof. Dr. Jamie Coleman

Jamie Coleman

Prof. Dr Jamie Coleman is a Professor in Clinical Pharmacology and Medical Education at the University of Birmingham, UK. He is an honorary consultant physician at the Queen Elizabeth Hospital Birmingham and is one of the leads for their locally-developed hospital electronic prescribing and medication administration system. Dr Coleman obtained his MBChB and MD at the University of Birmingham and has been on the faculty there since 2009 holding a competitively HEFCE funded senior clinical lectureship. He is deputy programme lead for the medical degree programme and has an extensive portfolio of teaching and research activities. Dr Coleman is a co-principal investigator on an NIHR-funded programme grant investigating the implementation and adoption of hospital electronic prescribing systems in England. His research interests include drug safety and medication errors, pharmacoepidemiology, adverse drug reactions, clinical decision support systems, and electronic prescribing. He is also on the specialist advisory committee for Clinical Pharmacology and Therapeutics in the UK and is a member of the Pharmacovigilance Expert Advisory Group at the MHRA. Contact

Prof. Dr. Peter Crome

Peter Crome

Professor Peter Crome is Emeritus Professor at Keele University, an Honorary Professor at UCL and the DeNDRoN lead for the West Midlands. He was Professor of Geriatric Medicine at Keele between 1994 and 2012. Prior to this he was a Senior Lecturer and Consultant at King’s College and Orpington Hospitals. He has served as Head of Keele Medical School, President of the British Geriatrics Society and of the Geriatrics and Gerontology Section of the RSM. He has served at Clinical Director in both Stoke and Orpington and has been responsible for the introduction of numerous services including memory clinics, stroke units, intermediate care and ortho-geriatrics. He chairs the steering committee of the National Audit of Dementia in acute hospitals. His research interests include stroke, dementia, medication in later life and health services research. Contact

Dr. Paul Jansen

Paul Jansen

Paul A.F. Jansen is geriatrician and clinical pharmacologist and is since 1992 member of staff at the department of Geriatrics University Medical Center Utrecht. Since 2000 he is trainer in Geriatric Medicine and since 2002 trainer in Clinical Pharmacology. He is university lecturer in year 3, 4, 5 and 6 of the study medicine and teacher in several postgraduate courses. The subject of his Ph-D thesis (28 November 1986) was "Antihypertensive treatment as possible cause of stroke in the elderly", Faculty of Medicine Catholic University Nijmegen The Netherlands. His scientific interest is pharmacology in the elderly. He is author of more than 100 national and international published scientific articles on effects and adverse effects of drugs in the elderly. In 2010 he raised the Expertisecentre Pharmacotherapy in Old Persons.  ( and Since 2006 he is member of the Dutch Medicine Evaluation Board. Since 2011 he is member of the Geriatric Expert Group of the European Medicine Agency (EMA). In 2012 he was awarded as best teacher of trainees in the Netherlands. Contact

Prof. Dr. Jose M. Ribera-Casado

Jose M. Ribera-Casado

Prof. Ribera Casado is Chair of Geriatrics Department (Hospital Clínico San Carlos, Universidad Complutense, Real Academia Nacional de Medicina. Between 1995 and 2001 he was Chairman of the Postgraduate Geriatric Teaching Program of the School of Medicine (Universidad Complutense). In the same period he has been President of the "Sociedad Española de Geriatría y Gerontología"of the Clinical section of IAGG-ER (Internacional Association of Geriatrics and Gerontology-European Region). Since 2006 Prof. Ribera Casado is main investigator of research grants and international multicentric trials (18) and president of the "Comisión Nacional de la Especialidad de Geriatría"uthor or editor of 53 books, author of 194 books chapters and 373 papers in scientific journals. His presence in the SENATOR project is associated to his large experience in geronto-geriatric field. Contact

Prof. Dr. Anne Spinewine

Anne Spinewine

Anne Spinewine is a professor of pharmacotherapy, clinical pharmacy and evidence-based medicine at the Université catholique de Louvain (UCL), Belgium ( She is also head of the clinical pharmacy service at CHU UCL Mont-Godinne Dinant, a teaching hospital affiliated to UCL. Anne Spinewine obtained her MPharm (1999), PhD (2006) and MSc in hospital pharmacy (2007) at UCL, and an MSc in clinical pharmacy, international practice and policy at the University of London (2001). She has pioneered the development of clinical pharmacy practice and education in Belgium since then. Her research interests include appropriateness of prescribing, use of medicines in older people, continuity of care.Contact